М. У. Раджапова, И. А. Гулидов, Ю. С. Мардынский, Д. Ю. Семин, В. С. Медведев, И. Н. Иванова СРАВНИТЕЛЬНАЯ ОЦЕНКА РАЗНОФРАКЦИОННОЙ ХИМИОЛУЧЕВОЙ И ЛУЧЕВОЙ ТЕРАПИИ БОЛЬНЫХ РАКОМ СЛИЗИСТОЙ ОБОЛОЧКИ ПОЛОСТИ РТА И РОТОГЛОТКИ ПО КРИТЕРИЮ "ЭФФЕКТИВНОСТЬ—ТОКСИЧНОСТЬ"
М. У. Раджапова, Игорь Александрович Гулидов, S. Mardynsky et al. · CyberLeninK (CyberLeninka) · 2012
Two hundred and thirty-three patients with primary cancer of the oral and otopharyngeal mucosa received chemoradiotherapy with unequal divisions of a daily dose and standard radiotherapy. After chemoradiotherapy with division of the dose of into 1 + 1.5 Gy and fractionation into 1 + 2 Gy, the rate of objective responses (a sum of complete and partial regressions) was signifi cantly higher than that following standard radiotherapy (97.8, 100, and 61.9%, respectively). During chemoradiation therapy in the 1 + 1.5 Gy and 1 + 2 Gy regimen, the incidence of Grade 3 mucositis was 40.5 and 77.8% (p 0.05). In terms of the early toxic effect – mucosal radiation reactions, variously fractionated chemotherapy is fairly tolerated by patients and, after it, there is no increase in late local toxicity as compared to the standard radiotherapy.
Cited by 0 works.